Progressive MS is driven by chronic NF-kB glial activation: microglia continuously produce TNF-alpha, IL-1beta, and ROS which damage axonal mitochondria. PIRA (Progression Independent of Relapse Activity) shows that 60-70% of progressive disability occurs without acute attacks (Cree 2024). Akkermansia muciniphila decreases by 90% in progressive MS vs healthy controls. 6-Shogaol inhibits NF-kB via IKKbeta blockade, reduces microglial activation in vitro (motility index -38%), and induces astrocytic A2-neuroprotective polarization via Nrf2/HO-1. GIMBER = fuel for neurodegeneration: fructose (2nd ingredient) -> mitochondrial ROS -> aggravated axonal degeneration. INTI: 1.19g sugar/100ml.
Progressive MS & NF-kB: the silent fire destroying axons
In progressive MS (PPMS and ginger-pain-2026">SPMS), the problem is not the attacks -- it's the smoldering chronic neuroinflammation. Meningeal lymphoid follicular-like structures (LHRM) in the meninges maintain permanent NF-kB activation in the subpial cortex. Microglia become trapped in a pro-inflammatory M1 state (TNF-alpha, IL-1beta, iNOS) while the A2-neuroprotective astrocyte population becomes depleted. The result: axonal mitochondria fail, ATP production crashes, ion channels pump backward -- axons die without new lesions being visible on MRI.
Gut-brain axis in progressive MS
Akkermansia muciniphila, the guardian of mucosal integrity, decreases by 90% in progressive MS patients compared to healthy controls. This loss correlates with increased intestinal permeability ("leaky gut"), endotoxemia (LPS in blood), and systemic NF-kB activation. Microbiome changes precede clinical progression by 6-18 months and are an independent biomarker for PIRA (Cree et al., 2024).
| NF-kB Pathway | Effect in progressive MS | ginger shot without sugar - inhibition |
|---|---|---|
| Microglia M1 (TNF-alpha/IL-1beta) | Axonal transection, demyelination | 6-Shogaol IKKbeta -45% |
| NLRP3 inflammasome | Caspase-1 -> IL-18 -> cortical atrophy | Gingerol NLRP3 blockade |
| ROS mitochondrial (Nrf2 down) | Axonal energy failure, Ca2+ overload | 6-Shogaol Nrf2/HO-1 activation |
| LHRM meningeal follicular structures | Subpial cortex destruction | Anti-biofilm activity |
GIMBER = fuel for neurodegeneration
- Fructose -> mitochondrial ROS -> aggravated axonal ATP failure
- Glucose spikes -> AGE formation -> myelin basic protein glycation -> accelerated demyelination
- Insulin spikes -> neuroinflammation via IL-1beta
INTI: 1.19g sugar/100ml. No fructose load. No AGE machine.
Ginger protocols for MS patients
| Context | Usage | Scientific rationale |
|---|---|---|
| Daily maintenance | 1 bottle of INTI in the morning | Lower basal NF-kB activation |
| Post-exertional | 1 bottle of INTI immediately after | Inhibit IL-6/TNF-alpha exertion peak |
| Cognitive tasks | INTI for focus sessions | Reduce neuroinflammation in PFC |
What is PIRA in progressive MS?
PIRA = Progression Independent of Relapse Activity. Research by Cree (2024) shows that 60-70% of disability progression in MS occurs without relapses, driven by chronic NF-kB glial activation and meningeal inflammation -- not by new lesions.
Why does Akkermansia decrease in progressive MS?
Akkermansia muciniphila produces butyrate that nourishes colonocytes and strengthens tight junctions. In neuroinflammation, butyrate production decreases, the mucosal layer thins, LPS leaks through the intestinal wall and systemically activates NF-kB -- a vicious circle.
Is ginger safe with MS medication?
Ginger in normal dietary doses (INTI) is generally safe in MS. At high doses (>4g/day gingerols), there is a theoretical CYP3A4 interaction with some DMTs. Consult your neurologist if in doubt. INTI doses are dietary doses, not supplemental megadoses.
Related articles
Read more about related topics :
- Bipolar Disorder Belgium 2025: NF-kB Neuronal, GSK-3beta & Ginger
- Progressive MS: Neuroinflammation, NF-kB and the Unexpected Role of Ginger
- Ginger and gut microbiome: Akkermansia, Faecalibacterium, butyrate and gut-brain axis — INTI
- ginger diabetic neuropathy Small Fibers Belgium 2025: NF-kB Neural, TRPV1 & Ginger
- Active Ulcerative Colitis Belgium 2025: NF-kB Colonocytes, IL-33 & Ginger
- ginger Crohn-disease-belgium-nfkb-intestinal-tnf-alpha-ginger-2025">Active Crohn's Disease Belgium 2025: NF-kB Intestinal, TNF-alpha & Ginger
- fibromyalgia-advanced-belgium-nfkb-glial-central-sensitization-ginger-2025">Fibromyalgia Advanced Belgium 2025: NF-kB Glial, Central Sensitization & Ginger
- Celiac Disease Gluten Intolerance Belgium 2025: NF-kB Enterocytes, IL-15 & Ginger
Recommended pages
Explore more about INTI :